Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)

Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)

Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered ‘never vaccinated’ and offered a comprehensive course of revaccination. This pos...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infection Vol. 86; no. 1; pp. 1 - 8
Main Authors: Miller, PDE, Patel, SR, Skinner, R, Dignan, F, Richter, A, Jeffery, K, Khan, A, Heath, PT, Clark, A, Orchard, K, Snowden, JA, de Silva, TI
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-01-2023
Subjects:
Adult
Bone Marrow
Child
Haematopoietic stem cell transplant
Hematopoietic Stem Cell Transplantation
Humans
Immunisation
Leukemia
Transplant Recipients
Vaccination
Vaccines
Haematopoietic stem cell transplant
Vaccination
Immunisation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered ‘never vaccinated’ and offered a comprehensive course of revaccination. This position statement aims to draw upon the current evidence base and existing guidelines, and align this with national vaccine availability and licensing considerations in order to recommend a pragmatic and standardised re-vaccination schedule for adult and paediatric HSCT recipients in the UK.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2022.11.005